Among the Best Children’s Pulmonology Programs in the Country
University Hospitals Rainbow Babies & Children’s Hospital is committed to the improvement of quality of life and outcomes for children with chronic and acute lung disease. With this dedication to excellence, the Rainbow pediatrics team consistently ranks among the top 20 in the nation for pediatric pulmonology care.
Your child’s health is important. Don’t delay care.Offering in-person, video and telephone visits. Call us today at
866-662-5931 to see which option is right for you.
Learn more about virtual visit
Pediatric Pulmonary Disorders We Treat
The highly specialized pediatric pulmonologists at UH Rainbow Babies & Children's work closely together and across multiple disciplines to diagnose, treat, manage and prevent various lung diseases in children , ranging from common breathing problems to rare pulmonary disorders.
Our pediatric pulmonology team provides expert care in the diagnosis and treatment for asthma, continuing to advance care for improved quality of life.
The pediatric pulmonary specialists at UH Rainbow Babies & Children’s are pioneers in advancing cystic fibrosis treatment.
Our board-certified pediatric sleep specialists lead the country in child-friendly sleep studies, diagnosis and treatment, making us one of the leading referral centers in the country.
Primary Ciliary Dyskinesia
With a focus on primary ciliary dyskinesia (PCD) treatment in both children and adults, UH Rainbow Babies & Children’s Hospital is home to the first fully accredited PCD Center in the U.S. and the only approved PCD center in Ohio.
One of a limited number of aerodigestive programs in Ohio, UH Rainbow Babies & Children’s brings together experts across multiple pediatric specialties to care for children with breathing, swallowing and digestive conditions.
Interstitial and Diffuse Lung Disease
Interstitial and diffuse lung diseases of childhood are a group of difficult to diagnose rare diffuse lung diseases that can affect babies, children and teenagers. These diseases are often referred to as childhood interstitial lung disease (chILD) or Diffuse Parenchymal Lung Diseases (DPLDs), these rare lung diseases are often identified within the first few months of life.
Children’s Rare Lung Diseases Program at UH Rainbow Babies & Children’s Hospital
What sets UH Rainbow Babies & Children's Hospital apart from other hospitals in treating interstitial lung diseases is a dedicated children's rare lung diseases program supported by a network of nationally recognized centers for the treatment of various lung disorders.
Dedication to the Best Pulmonary Care Quality
We hold ourselves to an incredibly high standard of quality in every aspect of care, keeping patients and their families at the center of treatment decisions and longer-term disease management. Our team focuses on the unique needs of children – from the right size beds and equipment, to the support of nursing, behavioral and respiratory therapists, and child life specialists. Our goal is to not only improve pulmonary outcomes for our pediatric patients but also improve their overall quality of life.
Multidisciplinary Team of Experts Dedicated to Children’s Lung Conditions
Our multidisciplinary pediatric team includes board-certified and fellowship-trained pediatric pulmonologists, pulmonary nurses , nurse practitioners, respiratory and physical therapists, dietitians and child life specialists. We take a compassionate, well-rounded approach to care, keeping the whole child top of mind. In addition, we work closely with other departments and specialties to coordinate care for children with complex medical conditions.
The pediatric pulmonology center at UH Rainbow Babies & Children’s Hospital leads a team that cares specifically for children who are dependent on ventilators, tracheostomy tubes or similar equipment to help them breathe. We employ a long-standing, multidisciplinary approach to the care of these medically complex and unique patients using up-to-date research and techniques. Our technology dependence clinic sees children of all ages who require respiratory support as result of prematurity, muscle weakness, lung disease and/or other indications.
Our national and international leadership and expertise in the area of pediatric respiratory care encompasses decades of clinical practice, professional education and clinical research.
Ranked #13 in the Country for Respiratory Care
A pioneer in advancing care and improving outcomes for cystic fibrosis, asthma, newborn lung disease, apnea and other respiratory conditions, UH Rainbow Babies & Children’s established one of the first cystic fibrosis centers in the U.S. and continues to rank among the nation’s leaders in conducting clinical trials for new cystic fibrosis treatment. Our physician-scientists translate discoveries into vital new therapies every day, including new drugs aimed at improving gene and protein function in cystic fibrosis patients.
Leading the Search for A Cure for Cystic Fibrosis
The LeRoy W. Matthews Cystic Fibrosis Center at UH Rainbow Babies & Children’s Hospital is world-renowned for its care of children and adults with cystic fibrosis and is fully accredited with the highest possible rating by the Cystic Fibrosis Foundation.
Over the years, Rainbow physicians have helped advance the science and practice of Cystic Fibrosis which in turn has worked to extend the life expectancy of CF patients. In specific, Rainbow physicians and scientists have developed successful anti-inflammation therapies and led the first human gene therapy trials in the country.
Cystic Fibrosis Clinic
Our cystic fibrosis clinic for both children and adults is held in the KC and Ginny Bryan Pulmonary Diagnostic Center on the main campus of UH Rainbow Babies & Children’s Hospital, in Cleveland, Ohio.
Advancing Standards of Care through Innovative Research
As a primary pediatric affiliate of Case Western Reserve University School of Medicine, we conduct ongoing research in pulmonology and sleep disorders. Through this partnership, we set national standards for care and treatment, improving the outcomes and lives of children every day. For example, our specialists are part of an elite team leading the country toward a better understanding of and care for interstitial lung disease in children. We are enrolling patients in a newly initiated national interstitial patient registry through which we compare treatment outcomes and collaborate with other pulmonology programs across the U.S.